Coronado Biosciences to Participate in Upcoming Healthcare Investor Conferences  
6/21/2013 9:38:21 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BURLINGTON, Mass., June 21, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today that Dr. Harlan F. Weisman, Coronado's Chairman and CEO, will participate in the following upcoming investor conferences:

Help employers find you! Check out all the jobs and post your resume.